qSTAR qPCR primer pairs against Homo sapiens gene TNF
Products
Human TNF-a ELISA Kit (96-well)
Type | Solid Phase Sandwich ELISA |
Format | 96-well strip plate |
Reactivity | Human |
TNF - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pGFP-V-RS |
Human TNF alpha ELISA Kit
Type | Sandwich ELISA kit of Quantitative Detection for Human TNF alpha |
Reactivity | Human |
Tumor necrosis factor (TNF-alpha) (77-233) human recombinant protein, 0.5 mg
Expression Host | E. coli |
Tumor necrosis factor (TNF-alpha) human recombinant protein, 50 µg
Expression Host | E. coli |
TNF - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pRS |
Tumor necrosis factor (TNF-alpha) human recombinant protein, 10 µg
Expression Host | E. coli |
Tumor necrosis factor (TNF-alpha) (77-233) human recombinant protein, 0.1 mg
Expression Host | E. coli |
Human TNF alpha ELISA Kit, 1 x 48-well (pre-coated)
Type | Solid Phase Sandwich ELISA |
Format | 1 x 48-well (pre-coated) |
qPCR primer pairs and template standards against Homo sapiens gene TNF
Application | Plasmid of exact quantity for transcript copy number calculation |
TNF - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Format | Lentiviral plasmids |
Vector | pGFP-C-shLenti |
Human TNF alpha ELISA Kit, 2 x 96-well (pre-coated)
Type | Solid Phase Sandwich ELISA |
Format | 2 x 96-well (pre-coated) |
TNF CRISPRa kit - CRISPR gene activation of human tumor necrosis factor
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Human TNF-a ELISA Kit (48-well)
Type | Solid Phase Sandwich ELISA |
Format | 48-well strip plate |
Reactivity | Human |
活动过滤器
优化搜索结果
Reactivities
Expression Hosts
Lentivirus
Vectors
Assay Types
Pathways
- Adipocytokine signaling pathway (4)
- Allograft rejection (4)
- Alzheimer's disease (4)
- Amyotrophic lateral sclerosis (ALS) (4)
- Apoptosis (4)
- Asthma (4)
- Cytokine-cytokine receptor interaction (4)
- Dilated cardiomyopathy (4)
- Fc epsilon RI signaling pathway (4)
- Graft-versus-host disease (4)
- Hematopoietic cell lineage (4)
- Hypertrophic cardiomyopathy (HCM) (4)
- MAPK signaling pathway (4)
- NOD-like receptor signaling pathway (4)
- Natural killer cell mediated cytotoxicity (4)
- RIG-I-like receptor signaling pathway (4)
- Systemic lupus erythematosus (4)
- T cell receptor signaling pathway (4)
- TGF-beta signaling pathway (4)
- Toll-like receptor signaling pathway (4)
- Type I diabetes mellitus (4)
- Type II diabetes mellitus (4)